MEI Pharma announced its first LTC purchase, sparking a rally for one of the oldest and well-established crypto coins.

San Diego-based MEI Pharma (NASDAQ:MEIP) has acquired 929,548 Litecoin (CRYPTO: LTC) tokens, becoming the first U.S.-listed ...

Analysts told Decrypt though ETF approval rumors are adding to optimism, it’s MEI Pharma’s buy-in last month that is really ...

EDT MEI Pharma (MEIP) files to sell 25.3M shares of common stock for holders Published first on TheFly – the ultimate source for real-time, ...

An update from MEI Pharma ( (MEIP) ) is now available.

Infinity Pharmaceuticals has scuttled a plan to combine with MEI Pharma, whose shareholders rebuffed the merger over the weekend, the company announced Monday morning. The announcement comes days ...

GSR, crypto’s capital markets partner, today announced an investment and strategic partnership with MEI Pharma, Inc. (NASDAQ:MEIP) (“MEI”), in which it will serve as both strategic advisor and digital ...

MEI Pharma is back at support levels where there has been significant buying interest - including a large private placement in 2018 that stoked a rally. The MEI Pharma pipeline is progressing well ...

MEI Pharma, Inc. (Nasdaq: MEIP) (the “Company” or “MEI”) today announced that it has closed its previously announced private placement for the purchase and sale of 29,239,767 shares of ...

Consensus from 7 of the American Biotechs analysts is that MEI Pharma is on the verge of breakeven. They expect the company to post a final loss in 2023, before turning a profit of US$8.4m in 2024.